Clover Biopharmaceuticals, Ltd. (2197.HK)

HKD 0.26

(0.0%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019
Total Assets 2.1 Billion 4.69 Billion 5.34 Billion 1.18 Billion 186.21 Million
Total Current Assets 1.89 Billion 4.38 Billion 5.07 Billion 1.04 Billion 164.34 Million
Cash And Short Term Investments 766.25 Million 1.64 Billion 2.86 Billion 806.51 Million 158.69 Million
Cash and Cash Equivalents 735.86 Million 1.6 Billion 2.76 Billion 516.18 Million 148.69 Million
Short Term Investments 30.39 Million 33.17 Million 98.79 Million 290.32 Million 10 Million
Net Receivables 24.1 Million -13.92 Million -30.9 Million -20 Million -
Inventory 696.97 Million 2.38 Billion 768.69 Million 50.88 Million 393 Thousand
Other Current Assets 426.34 Million 395.23 Million 1.47 Billion 211.03 Million 5.25 Million
Total Non-Current Assets 201.91 Million 304.77 Million 269.16 Million 139.1 Million 21.87 Million
Net PPE 162.05 Million 241.74 Million 222.4 Million 86.98 Million 17.42 Million
Good Will And Intangible Assets 39.85 Million 34.99 Million 13.82 Million 277 Thousand 294 Thousand
Good Will - - - - -
Intangible Assets 39.85 Million 34.99 Million 13.82 Million 277 Thousand 294 Thousand
Long-Term Investments -14.16 Million - - - -
Tax Assets - - - - -
Other Non Current Assets 14.16 Million 28.03 Million 32.93 Million 51.83 Million 4.14 Million
Other Assets - - - - -
Total Liabilities 2.83 Billion 5.36 Billion 4.12 Billion 2.17 Billion 254.03 Million
Total Current Liabilities 2.27 Billion 2.82 Billion 2.14 Billion 66.73 Million 27.48 Million
Account Payables 247.82 Million 856.96 Million 588.55 Million 33.82 Million 7.16 Million
Tax Payables 3.06 Million 6.28 Million 5.91 Million 1.42 Million 83 Thousand
Short Term Debt 326.59 Million 317.63 Million 21.48 Million 4.25 Million 1.81 Million
Deferred Revenue 1.7 Billion - - - -
Other Current Liabilities 525 Thousand 1.65 Billion 1.53 Billion 28.65 Million 18.51 Million
Total Non Current Liabilities 557.26 Million 2.53 Billion 1.97 Billion 2.1 Billion 226.55 Million
Long-Term Debt 7.85 Million 36.73 Million 46.44 Million 18.05 Million 10.64 Million
Deferred Revenue Non Current 44.36 Million 2.49 Billion 1.93 Billion 958.17 Million 17.17 Million
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 549.41 Million 2.49 Billion 1.93 Billion 1.12 Billion 198.73 Million
Other Liabilities - - - - -
Total Equity -732.83 Million -668.13 Million 1.21 Billion -982.74 Million -67.82 Million
Stock Holders Equity -732.83 Million -668.13 Million 1.21 Billion -982.74 Million -67.82 Million
Common Stock 838 Thousand 835 Thousand 742 Thousand - -
Retained Earnings -9.64 Billion -9.5 Billion -7.04 Billion -1.03 Billion -120.62 Million
Accumulated other comprehensive income -733.64 Million 270.38 Million 296.63 Million 50.78 Million 52.8 Million
Common Stock Equity -732.83 Million -668.13 Million 1.21 Billion -982.74 Million -67.82 Million
Capital Lease Obligation 26.38 Million 60.3 Million 67.92 Million 22.31 Million 12.45 Million
Total Investments 16.22 Million 33.17 Million 98.79 Million 290.32 Million 10 Million
Total Debt 334.45 Million 354.36 Million 67.92 Million 22.31 Million 12.45 Million
Net Debt -401.41 Million -1.25 Billion -2.69 Billion -493.86 Million -136.23 Million

Balance Sheet Charts